Crossmark

Modified protocol of omalizumab treatment to prevent carboplatin-induced drug hypersensitivity reactions: a case study

Crossref DOI link: https://doi.org/10.1186/s13601-020-0309-0

Published Online: 2020-01-29

Published Print: 2020-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Oude Elberink, Hanneke N. G.

Jalving, Mathilde

Dijkstra, Hilda

van de Ven, Annick A. J. M. http://orcid.org/0000-0001-7032-9571
License Information

Text and Data Mining valid from 2020-01-29
More Information

Article History

Received: 30 September 2019

Accepted: 12 January 2020

First Online: 29 January 2020

Ethics approval and consent for publication

: Informed consent for publication was provided by the patient.

: The authors declare that they have no competing interests.